Formation Bio Announces $600 Million Debut Fund to Expand Drug Development Capacity
AI-native pharmaceutical company, today announced the Formation Bio Drug Development Accelerator Fund (the “Fund”), with $600 million in capital commitments. The Fund is designed to expand the company’s portfolio...

